Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Medplus Health Services informed stock exchanges that its subsidiary, Optival Health Solutions Private Limited, received four drug license suspension orders from Drugs Control Administration authorities in Telangana. The suspensions were issued under Rule 65 of the Drugs and Cosmetics Act, 1940, and affect four stores located at Gadwel bus stand (1-day suspension), Kamareddy bus station road (1-day), Shailajapuri colony Mansoorabad (2-day), and Vinayaka nagar colony Mansoorabad road (2-day). The orders were received on May 31, 2025, and the company estimates a total potential revenue loss of approximately Rs 2.71 lacs across all four stores. The suspensions appear to be short-duration administrative actions rather than permanent closures.
The financial impact is negligible — under Rs 3 lacs in potential revenue loss across four out of Medplus's large nationwide store network, so this is unlikely to materially affect the stock price or business operations.